Art Advanced Research Technologies Incorporated - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Art Advanced Research Technologies Incorporated Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Art Advanced Research Technologies Incorporated. The Group's principal activities are to design, develop and market optical molecular imaging products for the healthcare and pharmaceutical industries. It has developed two products based on its innovative technology. The Group operates two segments: Pharmaceutical and Medical. The first is explore OptixTM, a molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs. The second is SoftScan(R), a medical imaging device designed to improve the diagnosis and treatment of breast cancer. The Group commercializes its products in a global strategic alliance with GE Healthcare.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report